Clin2
NCT05656664Possibly a fitEnrolling by invitation

Folic acid to reduce effects of arsenic exposure

Arsenic and/or Arsenic Compound Adverse Reaction

Treatments studied

This study tests whether taking folic acid can help reduce health effects from arsenic exposure in people living near a Superfund site. You would be enrolled only if you meet safety rules, including not being pregnant and not already taking folic acid.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 89 years
Study type
Interventional

Who can take part

  • Be at least 18 years old
  • Live in the Superfund area for this study
  • Have been medically stable with no major health changes in the last 4 weeks
  • Be able and willing to sign informed consent paperwork
  • Not be pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06670222Recruiting· Phase 1
Arsenic for low-risk MDS

This study tests an oral form of arsenic in people with low-risk myelodysplastic syndromes (MDS) who need regular red blood cell transfusions and haven't gotten enough benefit from standard treatments. It aims to see if this drug can help reduce transfusion needs.

Nice
NCT06450145Recruiting
Combination treatment for arsenic-resistant APL

This trial tests if combining interferon-α with arsenic trioxide (ATO) can help people whose acute promyelocytic leukemia (APL) has stopped responding to arsenic treatment. If you have this type of leukemia that came back or didn't get better after arsenic therapy, this study may offer a new option.

Hangzhou, Zhejiang
NCT06778187Recruiting· Phase 2
Oral arsenic therapy for TP53-mutated blood cancers

This trial tests a combination of oral medications, including arsenic trioxide, venetoclax, and a chemotherapy agent (azacitidine or decitabine), for people with certain blood cancers (AML, MDS, or CMML) that have a TP53 gene mutation. The goal is to see if this pill-based treatment can help control the cancer.

Hong Kong
NCT07740109Not yet recruiting
Folate supplement for fatty liver disease

This trial tests whether a form of folic acid (5-methyltetrahydrofolate) can help people with fatty liver disease. It may improve liver health by supporting fat and sugar processing.

Tabriz
NCT01687127Not yet recruiting
High-dose folic acid study to support DNA-building pathways

This study tests whether taking a high dose of folic acid changes body pathways involved in DNA (genetic material) formation. It may help researchers understand how folate affects cells, which could be relevant to health and growth.

Vancouver, British Columbia
NCT07630506Recruiting· Phase 2
Folinic Acid for Autism in Children Ages 3–10

This study tests whether folinic acid (a type of B vitamin) can help improve symptoms of autism in children. Researchers want to see if this supplement, combined with your child's current treatments, might make a difference.

Singapore, Singapore

Hear when a new Arsenic and/or Arsenic Compound Adverse Reaction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.